Crossmark Global Holdings, Inc. Neogenomics Inc Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$13.01 - $15.77 $10,954 - $13,278	842 Added 2.94%	29,494 $409,000
Q1 2024 May 13, 2024	BUY	$14.06 - $16.79 $89,899 - $107,355	6,394 Added 28.73%	28,652 $450,000
Q4 2023 Feb 13, 2024	SELL	$11.67 - $20.73 $1,202 - $2,135	-103 Reduced 0.46%	22,258 $360,000
Q3 2023 Nov 08, 2023	BUY	$12.15 - $17.85 $7,836 - $11,513	645 Added 2.97%	22,361 $285,000
Q2 2023 Jul 31, 2023	SELL	$14.1 - $19.83 $5,273 - $7,416	-374 Reduced 1.69%	21,716 $375,000
Q1 2023 May 12, 2023	BUY	$9.09 - $19.45 $11,853 - $25,362	1,304 Added 6.27%	22,090 $384,000
Q4 2022 Jan 19, 2023	SELL	$6.45 - $12.07 $1,141 - $2,136	-177 Reduced 0.84%	20,786 $192,000
Q3 2022 Nov 01, 2022	BUY	$7.86 - $12.91 $1,021 - $1,678	130 Added 0.62%	20,963 $181,000
Q1 2022 May 11, 2022	BUY	$12.15 - $35.28 $17,617 - $51,156	1,450 Added 7.48%	20,833 $254,000
Q4 2021 Jan 10, 2022	BUY	$30.49 - $48.49 $67,931 - $108,035	2,228 Added 12.99%	19,383 $661,000
Q3 2021 Oct 21, 2021	BUY	$41.66 - $52.52 $714,677 - $900,980	17,155 New	17,155 $828,000
Q3 2021 Oct 13, 2021	SELL	$41.66 - $52.52 $733,215 - $924,352	-17,600 Closed	0 $0
Q2 2021 Jul 21, 2021	SELL	$36.62 - $51.69 $3,295 - $4,652	-90 Reduced 0.51%	17,600 $795,000
Q1 2021 Apr 15, 2021	SELL	$41.56 - $59.88 $3,740 - $5,389	-90 Reduced 0.51%	17,690 $853,000
Q4 2020 Jan 14, 2021	BUY	$36.08 - $56.47 $53,037 - $83,010	1,470 Added 9.01%	17,780 $957,000
Q3 2020 Oct 08, 2020	BUY	$33.26 - $40.48 $3,326 - $4,047	100 Added 0.62%	16,310 $602,000
Q2 2020 Aug 14, 2020	BUY	$24.21 - $31.02 $3,147 - $4,032	130 Added 0.81%	16,210 $502,000
Q1 2020 Apr 28, 2020	SELL	$20.5 - $34.53 $4,100 - $6,906	-200 Reduced 1.23%	16,080 $443,000
Q4 2019 Feb 06, 2020	SELL	$18.96 - $29.84 $255,770 - $402,541	-13,490 Reduced 45.31%	16,280 $476,000
Q3 2019 Oct 09, 2019	BUY	$19.12 - $26.24 $2,294 - $3,148	120 Added 0.4%	29,770 $569,000
Q2 2019 Jul 09, 2019	SELL	$19.57 - $24.1 $23,288 - $28,679	-1,190 Reduced 3.86%	29,650 $651,000
Q1 2019 May 02, 2019	BUY	$12.14 - $20.46 $374,397 - $630,986	30,840 New	30,840 $631,000

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$322 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$230 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$113 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$108 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$107 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account